Literature DB >> 15459491

Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer.

Manabu Yamamoto1, Hideo Baba, Yoshihiro Kakeji, Kazuya Endo, Yasuharu Ikeda, Yasushi Toh, Shunji Kohnoe, Takeshi Okamura, Yoshihiko Maehara.   

Abstract

OBJECTIVE: Predicting peritoneal dissemination of cancer is very difficult whatever method of examination is used. Recently, a cytological examination of peritoneal lavage has been shown to be a feasible measure to predict an early state of peritoneal seeding. The predictive value of the levels of tumor markers in peritoneal lavage for peritoneal metastasis from gastric carcinoma was thus studied.
METHODS: In 229 patients gastric cancer tumor markers, CEA, CA 125, and CA 19-9, in peritoneal lavage were intraoperatively evaluated using a chemiluminescent enzyme immunoassay.
RESULTS: CEA in peritoneal lavage at a cutoff level of 0.5 ng/ml showed overall a higher sensitivity of 75.8% at a specificity of 90.8% for a diagnosis of peritoneal dissemination including cytologically positive peritoneal lavage [CY(+)] than CA 125 or CA 19-9 in peritoneal lavage. The CEA level in peritoneal lavage as well as both serosal invasion and the CA 125 level in peritoneal lavage were significant factors for the prediction of peritoneal dissemination including CY(+) with a relative risk of 6.6, 14.1 and 9.4. In patients undergoing curative operations, the recurrence rate for peritoneal dissemination and liver metastasis in cases with CEA levels in peritoneal lavage of > or = 0.5 ng/ml was significantly higher than that in cases with CEA levels of < 0.5 ng/ml (p < 0.0001, p < 0.002).
CONCLUSIONS: These finding suggest that the CEA level in peritoneal lavage is thus considered to be a predictor of peritoneal dissemination including CY(+). Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459491     DOI: 10.1159/000080281

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  15 in total

1.  CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma.

Authors:  Manabu Yamamoto; Keiji Yoshinaga; Ayumi Matsuyama; Shinichi Tsutsui; Teruyoshi Ishida
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-09       Impact factor: 4.553

2.  Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.

Authors:  Byung Chul Kim; Jung Hoon Bae; Sun Min Park; Dae Youn Won; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2019-12-05       Impact factor: 2.571

3.  Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.

Authors:  Zhen Li; Dewei Zhang; Hao Zhang; Zhifeng Miao; Yuanxin Tang; Gongping Sun; Dongqiu Dai
Journal:  Tumour Biol       Date:  2013-11-27

4.  Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?

Authors:  M Hasbahceci; F U Malya; E Kunduz; M Guzel; N Unver; A Akcakaya
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

5.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

Review 6.  Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives.

Authors:  Yoshiyuki Fujiwara; Yuichiro Doki; Hirokazu Taniguchi; Itsuro Sohma; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Morito Monden
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

7.  Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.

Authors:  Manabu Yamamoto; Hideo Baba; Yasushi Toh; Takeshi Okamura; Yoshihiko Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2007-01-17       Impact factor: 4.322

8.  Metachronous ovarian metastases following resection of the primary gastric cancer.

Authors:  Si-Youl Jun; Jong Kwon Park
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

9.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

10.  NY-ESO-1 antibody as a novel tumour marker of gastric cancer.

Authors:  S Fujiwara; H Wada; J Kawada; R Kawabata; T Takahashi; J Fujita; T Hirao; K Shibata; Y Makari; S Iijima; H Nishikawa; A A Jungbluth; Y Nakamura; Y Kurokawa; M Yamasaki; H Miyata; K Nakajima; S Takiguchi; E Nakayama; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.